Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025.
Zhu, Q. (2025) The Art of “Silence” in Interpersonal Communication. Open Journal of Modern Linguistics, 15, 69-77. doi: 10.4236/ojml.2025.151005 .